SmILE

About

SmILE is a European research project for the prevention and intervention of chronic musculoskeletal disorders that primarily affect older people. The aim is to use digital technologies such as sensor integration, AI-based data processing and a patient-centered platform to improve quality of life and reduce the burden on healthcare systems. SmILE strengthens self-determination in old age and contributes to sustainable, equitable healthcare in Europe.

Opportunity

Non-communicable diseases such as osteoporosis, osteoarthritis and rheumatoid arthritis are on the rise as a result of demographic change. They lead to chronic pain, loss of mobility and an enormous burden on healthcare systems. Especially in old age, there is often a lack of continuous care and early intervention. SmILE addresses precisely this gap with intelligent technologies that improve prevention, monitoring and intervention.

Solution/Product description

SmILE is developing a universally applicable chip platform for integration into medical devices, supplemented by a digital health platform for older people. This collects data from wearables, implants and questionnaires and processes it using AI. Patients receive personalized recommendations and can monitor their health independently. This enables more precise diagnoses, innovative treatment options and better everyday care.

Why Us

As the coordinating partner, Fraunhofer IMTE contributes extensive experience from interdisciplinary healthcare and technology fields. SmILE combines state-of-the-art medical technology, AI and social inclusion to create a unique data-driven healthcare concept. In a strong EU consortium with 25 partners from 12 countries, a platform is being created that is not only technologically innovative, but also socially transformative.

Funded by the European Union under the Horizon Europe grant agreement No. 101136376 (project SmILE), and from the Swiss State Secretariat for Education, Research and Innovation (SERI). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union nor European Health and Digital Executive Agency (HaDEA). Neither the European Union nor HaDEA can be held responsible for them.